Activation of the PI3K‐AKT pathway in classical NF1 may therefore account for tumour formation, as the pathway is activated in other tumour forming syndromes: neurofibromatosis 2, Cowden, CLOVES and tuberous sclerosis.36 The gene discussed is NF1; the disease is NF2-related schwannomatosis.